“Once-Daily Intravenous Busulfan As Myeloablative, Reduced-Toxicity Conditioning Regimen: Results in Young and Adult Patients With Hematological Malignant and Nonmalignant Diseases”. Hematology Meeting Reports (formerly Haematologica Reports) 2, no. 6 (June 23, 2009). Accessed June 20, 2025. https://journals.pagepress.org/hmr/article/view/771.